152 related articles for article (PubMed ID: 12920859)
1. Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET.
Hackman T; Doubrovin M; Balatoni J; Beresten T; Ponomarev V; Beattie B; Finn R; Bornmann W; Blasberg R; Tjuvajev JG
Mol Imaging; 2002; 1(1):36-42. PubMed ID: 12920859
[TBL] [Abstract][Full Text] [Related]
2. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography.
Tjuvajev JG; Avril N; Oku T; Sasajima T; Miyagawa T; Joshi R; Safer M; Beattie B; DiResta G; Daghighian F; Augensen F; Koutcher J; Zweit J; Humm J; Larson SM; Finn R; Blasberg R
Cancer Res; 1998 Oct; 58(19):4333-41. PubMed ID: 9766661
[TBL] [Abstract][Full Text] [Related]
3. Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression.
Brust P; Haubner R; Friedrich A; Scheunemann M; Anton M; Koufaki ON; Hauses M; Noll S; Noll B; Haberkorn U; Schackert G; Schackert HK; Avril N; Johannsen B
Eur J Nucl Med; 2001 Jun; 28(6):721-9. PubMed ID: 11440032
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy.
Tjuvajev JG; Finn R; Watanabe K; Joshi R; Oku T; Kennedy J; Beattie B; Koutcher J; Larson S; Blasberg RG
Cancer Res; 1996 Sep; 56(18):4087-95. PubMed ID: 8797571
[TBL] [Abstract][Full Text] [Related]
7. In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU.
Haubner R; Avril N; Hantzopoulos PA; Gansbacher B; Schwaiger M
Eur J Nucl Med; 2000 Mar; 27(3):283-91. PubMed ID: 10774880
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir.
Deng WP; Yang WK; Lai WF; Liu RS; Hwang JJ; Yang DM; Fu YK; Wang HE
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):99-109. PubMed ID: 14513292
[TBL] [Abstract][Full Text] [Related]
9. PET of cardiac transgene expression: comparison of 2 approaches based on herpesviral thymidine kinase reporter gene.
Miyagawa M; Anton M; Haubner R; Simoes MV; Städele C; Erhardt W; Reder S; Lehner T; Wagner B; Noll S; Noll B; Grote M; Gambhir SS; Gansbacher B; Schwaiger M; Bengel FM
J Nucl Med; 2004 Nov; 45(11):1917-23. PubMed ID: 15534063
[TBL] [Abstract][Full Text] [Related]
10. Quantitative kinetics of [124I]FIAU in cat and man.
Jacobs A; Bräunlich I; Graf R; Lercher M; Sakaki T; Voges J; Hesselmann V; Brandau W; Wienhard K; Heiss WD
J Nucl Med; 2001 Mar; 42(3):467-75. PubMed ID: 11337525
[TBL] [Abstract][Full Text] [Related]
11. Myocardial kinetics of reporter probe 124I-FIAU in isolated perfused rat hearts after in vivo adenoviral transfer of herpes simplex virus type 1 thymidine kinase reporter gene.
Simões MV; Miyagawa M; Reder S; Städele C; Haubner R; Linke W; Lehner T; Epple P; Anton M; Schwaiger M; Bengel FM
J Nucl Med; 2005 Jan; 46(1):98-105. PubMed ID: 15632039
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of cellular kinetics of reporter probe [(131)I]FIAU in neonatal cardiac myocytes after transfer of HSV1-tk reporter gene with two vectors.
Lan X; Yin X; Wang R; Liu Y; Zhang Y
Nucl Med Biol; 2009 Feb; 36(2):207-13. PubMed ID: 19217533
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of F-18-labeled 5-iodocytidine (18F-FIAC) as a new potential positron emission tomography probe for herpes simplex virus type 1 thymidine kinase imaging.
Chan PC; Wu CY; Chang WY; Chang WT; Alauddin M; Liu RS; Lin WJ; Chen FD; Chen CL; Wang HE
Nucl Med Biol; 2011 Oct; 38(7):987-95. PubMed ID: 21982570
[TBL] [Abstract][Full Text] [Related]
14. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
[TBL] [Abstract][Full Text] [Related]
15. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression.
Tjuvajev JG; Doubrovin M; Akhurst T; Cai S; Balatoni J; Alauddin MM; Finn R; Bornmann W; Thaler H; Conti PS; Blasberg RG
J Nucl Med; 2002 Aug; 43(8):1072-83. PubMed ID: 12163634
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy.
Blasberg RG; Tjuvajev JG
Q J Nucl Med; 1999 Jun; 43(2):163-9. PubMed ID: 10429512
[TBL] [Abstract][Full Text] [Related]
17. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG
Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of herpes simplex virus 1 thymidine kinase-mediated trapping of (131)I FIAU and prodrug activation of ganciclovir as a synergistic cancer radio/chemotherapy.
Schipper ML; Goris ML; Gambhir SS
Mol Imaging Biol; 2007; 9(3):110-6. PubMed ID: 17294333
[TBL] [Abstract][Full Text] [Related]
19. A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs.
Likar Y; Dobrenkov K; Olszewska M; Vider E; Shenker L; Cai S; Pillarsetty N; Hricak H; Ponomarev V
J Nucl Med; 2008 May; 49(5):713-20. PubMed ID: 18413388
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
